Journal articles
Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines
Abstract : The rapid spread, severity, and lack of specific treatment for COVID-19 resulted in hasty drug repurposing. Conceptually, trials of antivirals were well-accepted, but twentieth century antimalarials sparked an impassioned global debate. Notwithstanding, antiviral and immunomodulatory effects of aminoquinolines have been investigatedin vitro, in vivoand in clinical trials for more than 30 years. We review the mechanisms of action of (hydroxy)chloroquine on immune cells and networks and discuss promises and pitfalls in the fight against SARS-CoV-2, the agent of the COVID-19 outbreak.
https://hal-amu.archives-ouvertes.fr/hal-03149722
Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Tuesday, February 23, 2021 - 11:53:53 AM
Last modification on : Monday, May 23, 2022 - 3:44:03 PM
Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Tuesday, February 23, 2021 - 11:53:53 AM
Last modification on : Monday, May 23, 2022 - 3:44:03 PM
Links full text
